Breast Cancer Trial, By Invitation NCT06765707 Sponsor: Medical College of Wisconsin Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, By Invitation

NCT06765707
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are cisgender women assigned female at birth
  • People who are 18 years of age or older
  • People who have been diagnosed with Stage 1, 2, or 3 hormone receptor-positive breast cancer
  • People who are premenopausal and are receiving a type of medication (GnRH agonist or antagonist) to temporarily stop their ovaries from producing hormones
  • People who have previously been treated with a type of cancer medication called CDK 4/6 inhibitors
  • People whose doctor has recommended they continue hormone-blocking treatment (called adjuvant endocrine therapy, or AET) for at least 2 more years after joining the trial
  • People who have a history of not consistently filling their hormone-blocking medication prescriptions (covering less than 80% of days over the past 2 years), or whose adherence cannot be calculated
  • People who can speak and understand English or Spanish
  • People who are able to understand what the study involves and are willing to sign a consent form

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are unable to demonstrate understanding of the study, or whose ability to make decisions is impaired
  • People whose breast cancer has spread to distant parts of the body (metastatic disease)
  • People who are not receiving their breast cancer care or hormone-blocking medication prescription from a provider at one of the participating trial locations
  • People whose cancer specialist (oncologist) has already decided to stop their hormone-blocking treatment
  • People who are pregnant or are trying to become pregnant
  • People who receive their medications administered by a facility such as a nursing home or home healthcare agency

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 29 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Medical College of Wisconsin
Registry
ClinicalTrials.gov
Start date
23 June 2025
Est. completion
1 December 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Medication adherence; Intervention durability on medication adherence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov